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This paper investigates the eﬀects of very-low-calorie diets (VLCDs) used in the treatment of obesity on high-density lipoprotein
(HDL) levels. Although the studies varied widely in their intervention format, duration, and baseline HDL levels, it would
appear that HDL levels usually decrease during active weight loss using a VLCD, but these either return to pre-VLCD levels or
improve overall during the weight-maintenance phase. More research needs to be done to determine optimal weight-maintenance
programmes and the eﬀects of VLCDs in the short term as well as on HDL levels in groups at increased risk of coronary heart
disease.
1.Introduction
With the continuous rise in obesity, there has been resur-
g e n c ei nt h eu s eo fv e r yl o wc a l o r i ed i e t s( V L C D s )a n d
more research investigating the eﬀects of such diets has
beenundertaken. VLCDs haveoften beencriticised forbeing
unsafe and an unhealthy way to lose weight. The current
VLCDs, however, are not to be confused with those from
the 1970s which resulted in a number of deaths, probably
due to vitamin and mineral deﬁciencies and poor quality or
inadequate amounts of protein [1, 2]. VLCDs are deﬁned as
diet replacements with <800kcal and >400 to 450kcal/d [3].
There are now a number of commercially available VLCDs.
Evidencefrom a number ofreviews [3–5] clearlydemon-
strates that VLCDs can result in signiﬁcant weight loss.
Despite this, there are still concerns about weight regain
following these diets as well as detrimental health eﬀects due
to the rapid weight loss they induce. In this paper, we aim to
examine the literature and to investigate the eﬀects of very
low calorie diets on high density lipoproteins (HDL) levels
speciﬁcally.
2.Importanceof HDL
Obesity is commonly associated with elevated triacylglyc-
erols, low HDL, and normal low-density lipoproteins [6].
The low HDL observed in obesity is associated with an
enhanced risk of atherogenesis possibly due to increased
degradation and/or decreased production of HDL particles.
Adipose cells have been shown to bind to HDL [7], hence
increased body fat may lead to an increased uptake of HDL
particles from circulation resulting in a reduction in plasma
HDL levels [8]. On the other hand, an increase in HDL
has been associated with decreased risk of coronary artery
disease [9], probably due to its role in the reverse cholesterol
transport process where cholesterol in peripheral tissues is
transported to the liver for reuse or bile acid synthesis,
preventing the accumulation of cholesterol in the arteries
[10]. HDL is also thought to be cardioprotective due to its
antioxidant activity [11].
3.EffectofVLCDonHDL Levels
Several studies have investigated changes in HDL after a
period of VLCD. In Table 1,w er e p o r tt h eﬁ n d i n g sf r o m
5 studies in which participants underwent VLCDs for as
little as 2 days and as long as 12 weeks. The calorie intake
varied from 450–800kcal/day. One study [12] looked at the
diﬀerences in ethnicity in response to a VLCD delivered
with exercise and behavioural therapy. Also, the gender
composition of the studies were quite diﬀerent, as some
studies looked at women only [12, 13], while the other2 Cholesterol
studies all included men [14–16]. Weight loss was signiﬁcant
in all but the 2-day VLCD group [13].
With the exception of the group that underwent a
VLCD for 2 days [13], changes in HDL are reported in
Table 1.HDLwassigniﬁcantlydecreasedintwoofthestudies
[12, 14]. Hong et al. [12]i n v e s t i g a t e dt h ed i ﬀerences in
response between blackandwhite individuals. Their ﬁndings
demonstrated that there was no diﬀerence between these
two ethnic groups for weight and HDL in response to the
VLCD intervention (which also included behaviour therapy
and exercise).
Two other studies also displayed a trend for a decrease
in HDL [13, 16]. In the study by Lin et al. [16], all patients
underwent two weeks of an LCD followed by 12 weeks of
VLCD. The two groups diﬀered in the caloric intake during
the VLCD period (450 versus 800kcal/day). Weight loss and
changesinHDLwerenotsigniﬁcantbetweenthetwogroups.
Only one study reported an increase in HDL after a 9-
week VLCD [15], but this was not signiﬁcant.
4.EffectofVLCDand a Weight-Maintenance
Period on HDL Levels
A number of studies investigated changes in HDL after a
VLCD and a weight-maintenance period (Table 2). These
studies varied in duration of VLCD (6 weeks–9 months),
maintenance period/followup (4 weeks–5 years). Energy
intakefortheVLCDvariedfrom400–800kcal/d.Twostudies
included exercise [17, 18], while three other studies included
behaviourtherapy[19–21],fourstudiesincludedmedication
[22–25] and two studies investigated individuals with type 2
diabetes [21, 26]. Weight loss was signiﬁcant for all studies
after the VLCD, although one study [18] included an LCD
phase before the VLCD, another study [21] included a
refeeding phase before the measurements were taken, and a
third study reported BMI but not weight, and BMI change
was not reported after the period of VLCD [26]. Weight loss
at the end of the study remained signiﬁcant in 9 of the 12
studies. As mentioned previously, the study by Paisey et al.
[26] only reported BMI which did not change signiﬁcantly.
The changes in the study by Fogelholm et al. [18]w e r em o r e
diﬃcult to report for both weight and HDL as the baseline
values were reported for all of the participants and not
provided separately for each treatment group. In addition,
this study did not give within group signiﬁcance for changes
in weight or HDL at followup. Finally, Apfelbaum et al. [25]
only report weight change from the time of randomisation
after the VLCD to the end of the study, therefore not
including the weight loss achieved using the VLCD.
At the end of the VLCD phase, HDL was reported for
9 of the 12 studies. HDL was decreased in at least one of
the treatments for 6 of the studies [18, 20, 22, 23, 27, 28].
This was signiﬁcant in three studies [20, 22, 28] and not
reported in two others [18, 23]. Four studies [19, 21, 24, 27]
reported an increase in HDL after the VLCD, only one of
which was not signiﬁcant [27], however, the 2 studies that
report an increase in HDL had a period of refeeding before
the measurement [19, 21]. All of the studies reported an
increase in HDL at the end of the study with the exception
of Haugaard et al. [28] and one arm in the study by
Christiansen et al. [17] which both showed no change in
H D L .T h ei n c r e a s ei nH D Lw a ss i gn i ﬁ c a n ti na tl e a s to n ea r m
of 8 [17, 19–22, 24, 25, 27] out of the 12 studies.
The study by Christiansen et al. [17] reports that exercise
results in a signiﬁcant improvement on HDL while the study
by Fogelholmet al. [18] shows a similar trend, butthe results
were not signiﬁcant at the 2 year followup.
Delbridgeetal.[27],donotr eportasigniﬁcantdiﬀerence
in the improvement in HDL at the time of followup
between the high-carbohydrate and the high-protein weight-
maintenance group. Also, there were no signiﬁcant diﬀer-
ences in HDL between the use of a placebo and Orlistat
[22] or between placebo and the neuropeptide 5 receptor
antagonist MK-0557 [23] for weight maintenance, but there
was a signiﬁcant improvement in HDL when Sibutramine
was used compared to placebo [25].
5. EffectofIntermittent Use ofVLCDon
HDL Levels
Fivestudiesreported theeﬀectsofintermittentuse ofVLCDs
on HDL (Table 3). The duration of the studies varied from
14 weeks to over two years. The energy intake from VLCDs
ranged from 400–600kcal/d. Two studies included women
only [29] and one study included type 2 diabetic patients
only [30]. The format of the diﬀerent interventions varied
widely, and is described in more detail in Table 3.
Only three studies reported weight loss after the ﬁrst
phase of VLCD [8, 21, 31] and all three studies report a
signiﬁcant weight loss. Weight loss at the end of the study
was signiﬁcant for all ﬁve studies.
HDL change was reported after the ﬁrst phase of VLCD
in all 5 studies.Atthisstage, HDLhad decreased signiﬁcantly
in4studies[8,29,30],andincreasedinonestudy[21].Atthe
end of the studies, HDL was increased in at least one arm of
3 studies [21, 30, 31], only two of which were signiﬁcant [21,
31].HDLdecreasedinatleastonearm of3studies[8,29,30]
none of which were signiﬁcant.
6.Discussion
Here we reviewed the limited information available about
the eﬀects of VLCDs available. The results suggest that
althoughanimprovementinHDLlevelsduringactiveweight
loss using a VLCD is not always present, there often is an
improvement observed during weight maintenance.
It was interesting to see in the study by Lin et al. [16]
that there was no signiﬁcant diﬀerence in weight loss and
HDLbetweenthegroupthatconsumed450kcal/dcompared
to the group that consumed 800kcal/d. This is consistent
with other studies that compared the use of diets ranging
from 240–880kcal/d and found no signiﬁcant diﬀerence in
weight loss for short (4–6weeks) and intermediate term (16–
26 weeks) [32–34]. In light of this, it could be beneﬁcial for
patients to be allowed to consume more and minimise the
sense of limitation that occurs when using a VLCD, and use aCholesterol 3
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.8 Cholesterol
combination of liquid diet supplemented with lean meats or
low-starch vegetable.
From the studies presented in this paper, it appears that
HDL initially decreases during weight loss treatment using
VLCDs, but then either increases back to baseline levels
or result in an overall improvement of HDL levels during
weight maintenance. This biphasic response may explain
the discrepancies between the studies presented here. HDL
particlesarecomprisedofseveralsubfractions: HDL2,HDL 3,
apolipoprotein A-I (Apo A-I), apolipoprotein A-II (Apo A-
II), and pre-β1.H D L 2,A p oA - I ,a n dp r e - β1 are associated
with cardioprotection and are found to be reduced in the
obesity [35]. In response to the VLCD, Shoji et al. [29]
observed that the initial decrease in HDL2 was associated
with decreased lecithin cholesterol ester transfer protein
(LCAT) (which plays an important role in the formation
of HDL2 [36]) while Apo A-1 increased. Apo A-1 activates
LCAT, which may explain the delayed improvement in HDL
[29]. This observation is consistent with the meta-analysis
by Dattilo and Kris-Etherton [37] that reported a decrease
during active weight loss but an increase in HDL when
weight loss was stabilised after a dietary intervention. More
information, however, will be required to correlate weight,
Apo-A1, and LCAT metabolism changes with HDL changes
to allow a deﬁnitive comment on this parameter.
It has been suggested that exercise increases HDL
cholesterol. In the studies reviewed here, Christiansen et al.
displayed a signiﬁcant increase in HDL. Fogelholm et al.
[18]s h o w e das i m i l a rt r e n d ,b u tt h i sw a sn o ts i g n i ﬁ c a n ta t
2 years. This was probably due to the fact that there was
no diﬀerence in the number of steps taken between the
diﬀerent interventions at the end of the study, suggesting
a poor compliance to exercise. Exercise has been associated
withincreases inHDLcholesterol,althougharelatively high-
intensity exercise is required for signiﬁcant changes in HDL.
It is thought that the increase in HDL in response to exercise
is due to an increase in the activity of lipoprotein lipase
(which transfers lipids to HDL) and a reduction in the
activity of hepatic lipase (which removes lipids HDL in the
blood) [38]. It has also been suggested that the degree of
change in HDL in response to exercise may be dependent on
genetic factors [39, 40].
The main concern about the use of VLCDs is the weight
regain that is often observed after use. To date, there has
not been any solution to the almost inevitable long-term
weight regain associated with weight loss in general. While
also focusing on the prevention of weight regain, however,
it is important to also concentrate on maintaining the
health beneﬁts (i.e., increased HDL) associated with the
initial weight loss. The study by Delbridge et al. [27]w a s
quite interesting where they compared a high-carbohydrate
to a high-protein weight-maintenance diet for a period of
12 months. Although there was a trend for an increase
in HDL in both groups, there was no diﬀerence between
the two weight-maintenance diets. This is inconsistent with
the literature where it has been shown that at 12 months,
HDL levels are generally higher in patients who followed
a high-protein diet compared to a high-carbohydrate diet
[41]. The eﬀect of the weight maintenance diet in the study
by Delbridge et al. [27] may have been blurred by the
initial weight loss achieved using the VLCD, or by lack of
compliance to the diet.
The eﬀect of medication for weight maintenance on
HDL could also be interesting to investigate. Four studies
incorporated the use of obesity medication. One of the
studies investigating the use of Orlistat showed no signiﬁcant
diﬀerence in HDL levels in the longer term [22]w h i l e
the other study clumped their data for the placebo and
Orlistat group for their overall analysis [24]. Erondu et
al. [23] did not report a signiﬁcant change in HDL at 1-
year followup after randomisation to the neuropeptide-Y
receptor agonist MK-0557. The study investigating the use
of Sibutramine for weight maintenance, however, did report
a long-term improvement in HDL. From other studies, it
wouldappearthatSibutramine[25,42]anddexfenﬂuramine
[43]m a yb em o r ee ﬀective for weight maintenance after
aV L C Dc o m p a r e dt oO r l i s t a t[ 15, 22, 44] or MK-0557
[23]. More research into the eﬀect of Sibutramine on weight
maintenance and the beneﬁts on HDL should be pursued.
The main diﬃculty encountered was the heterogeneity
of the studies reviewed here. There was a wide variety of
intervention strategies, duration, and baseline HDL levels
(ranging from 1.05 to 1.50mmol/L) which makes it very
diﬃcult to reach clear conclusions and supply recommen-
dations for best practice. In addition, there is a paucity of
evidence for populations at increased risk of coronary artery
disease such as type 2 diabetics, gender, and diﬀerent ethnic
groups. There is an obvious need for more research and
better deﬁned intervention strategies for the use of VLCDs
in long-term treatment.
7.Conclusion
The results from this paper suggest that HDL can be
improved in the longer term by using a combination of
a VLCD followed by a weight-maintenance period using a
hypocaloric diet. Nevertheless, the studies reviewed here are
very heterogeneous and more research needs to be carried
out to deﬁne the short-term eﬀect of weight loss on HDL
levels as well as investigating the eﬀects of VLCDs in groups
at higher risk of coronary heart disease such as type 2
diabetics.
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